InsiderClue
Insiders · Profile

SIGAL ELLIOT

EVP, CSO & President R&D at Bristol Myers Squibb. Filing since 30 Apr 2009. CIK 0001202294

Company
Date
Role
Action
Shares
Amount
Of holding
BMY Bristol Myers Squibb
3 Jun 2013
EVP, CSO & President R&D
Sold, plan not stated
83,647
$4.03M
36.1%
BMY Bristol Myers Squibb
30 May 2013
EVP, CSO & President R&D
Sold, plan not stated
143,521
$6.78M
51.9%
BMY Bristol Myers Squibb
30 Apr 2013
EVP, CSO & President R&D
Sold, plan not stated
353,509
$14.00M
77.0%
BMY Bristol Myers Squibb
30 Apr 2013
EVP, CSO & President R&D
Sold, plan not stated
919
$36.44K
4.8%
BMY Bristol Myers Squibb
30 Apr 2013
EVP, CSO & President R&D
Sold, plan not stated
919
$36.44K
4.8%
BMY Bristol Myers Squibb
30 Apr 2013
EVP, CSO & President R&D
Sold, plan not stated
459
$18.20K
4.8%
BMY Bristol Myers Squibb
29 Apr 2013
EVP, CSO & President R&D
Sold, plan not stated
104,918
$4.19M
40.6%
BMY Bristol Myers Squibb
29 Apr 2013
EVP, CSO & President R&D
Sold, plan not stated
18,313
$731.97K
48.9%
BMY Bristol Myers Squibb
29 Apr 2013
EVP, CSO & President R&D
Sold, plan not stated
18,313
$731.97K
48.9%
BMY Bristol Myers Squibb
29 Apr 2013
EVP, CSO & President R&D
Sold, plan not stated
9,157
$366.01K
48.9%
BMY Bristol Myers Squibb
8 Feb 2013
EVP, CSO & President R&D
Sold, plan not stated
224,705
$8.27M
71.5%
BMY Bristol Myers Squibb
11 Dec 2012
EVP, CSO & President R&D
Sold, plan not stated
62,903
$2.08M
62.7%
BMY Bristol Myers Squibb
11 Dec 2012
EVP, CSO & President R&D
Sold, plan not stated
62,903
$2.08M
62.7%
BMY Bristol Myers Squibb
11 Dec 2012
EVP, CSO & President R&D
Sold, plan not stated
31,451
$1.04M
62.7%
BMY Bristol Myers Squibb
18 May 2011
EVP, CSO & President R&D
Sold, plan not stated
730
$20.95K
0.2%
BMY Bristol Myers Squibb
16 May 2011
EVP, CSO & President R&D
Sold, plan not stated
70,805
$2.05M
16.0%
BMY Bristol Myers Squibb
15 Mar 2010
EVP, CSO & President R&D
Sold, plan not stated
47,563
$1.23M
25.1%
BMY Bristol Myers Squibb
23 Dec 2009
EVP, CSO & President R&D
Sold, plan not stated
12,594
$0.00
7.6%
BMY Bristol Myers Squibb
30 Apr 2009
EVP, CSO & President R&D
Bought
15,000
$287.70K
9.2%
19 decisions on file.